Pelican BioThermal

Executive Summary

Pelican BioThermal is a leading provider of temperature-controlled packaging solutions for the biopharmaceutical industry. Founded in 2005 and headquartered in Minneapolis, Minnesota, the company specializes in reusable passive containers that ensure the integrity of temperature-sensitive drugs during transport. Its latest innovation, the Credo Vault, sets new standards in the reusable passive bulk container market, offering enhanced reliability and cost-effectiveness. With a reputation for quality and forward-thinking innovation, Pelican BioThermal serves clients globally, addressing the critical need for safe and efficient cold chain logistics. The company is privately held and has demonstrated steady growth by continuously introducing advanced solutions that meet evolving regulatory and operational demands. As the biopharma sector expands, particularly in biologics and cell and gene therapies, demand for sophisticated thermal packaging is expected to rise. Pelican BioThermal is well-positioned to capitalize on this trend through its established product portfolio and customer-centric approach. However, the competitive landscape includes both large logistics providers and specialized packaging firms, requiring ongoing innovation to maintain market share.

Upcoming Catalysts (preview)

• Q3 2026Commercial launch and adoption of Credo Vault reusable bulk container80% success
• Q4 2026Expansion into emerging Asian biopharma markets60% success
• Q2 2027Strategic partnership with a top-20 pharmaceutical company50% success